EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002)

Kyung Hee Han iD, Eunjung Yang iD, Namkyeong Kim iD, Joo-Hyuk Son iD, Tae Wook Kong iD, Seung-Hyuk Shim iD, Dong Hoon Suh iD, Suk-Joon Chang iD, Hee Seung Kim iD

Journal of Gynecologic Oncology · 2026

DOI: 10.3802/jgo.2026.37.e89 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Kyung Hee Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Hysterectomy, Lymph Node Excision, Chemoradiotherapy. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Agency for R&D Outcomes, Korea Institute of Startup & Entrepreneurship Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To compare the effectiveness and adverse events of primary chemoradiation versus radical hysterectomy with pelvic or para-aortic lymphadenectomy in patients with 2018 International Federation of Gynecology and Obstetrics stage IIICr cervical cancer without clinical parametrial involvement. METHODS: This retrospective study included patients diagnosed with stage IIICr cervical cancer who had pelvic or para-aortic lymph nodes measuring at least 1 cm in short diameter on preoperative imaging between 2000 and 2020. Primary chemoradiation consisted of external beam radiation therapy and brachytherapy, while adjuvant chemoradiation following radical surgery was administered based on pathological results. RESULTS: A total of 204 patients underwent primary chemoradiation (n=66) or radical hysterectomy with systematic lymphadenectomy (n=138). There were no significant differences in disease stage or histological type between the groups. In patients with tumors ≥4 cm, primary chemoradiation improved progression-free survival (PFS) compared to radical surgery (5-year survival: 91.1% vs. 61.7%; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsHysterectomyLymph Node ExcisionChemoradiotherapyHumansFemaleRetrospective StudiesMiddle AgedNeoplasm StagingAdultAgedChemoradiotherapy, AdjuvantLymphatic Metastasis

Stichwörter der Autor:innen

ChemoradiotherapyHysterectomyLymphatic MetastasisTumor BurdenUterine Cervical Neoplasms

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Research Institute of Medical Science, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
  • Department of Obstetrics and Gynecology, Korea University Guro Hospital, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
  • Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.

ORCID-Profile: Kyung Hee Han, Eunjung Yang, Namkyeong Kim, Joo-Hyuk Son, Tae Wook Kong, Seung-Hyuk Shim, Dong Hoon Suh, Suk-Joon Chang, Hee Seung Kim

Förderung

  • National Research Foundation of Korea
  • Agency for R&D Outcomes
  • Korea Institute of Startup & Entrepreneurship Development
  • Seoul National University Hospital
  • Korea Technology and Information Promotion Agency

Zitieren

APA

Han, K. H., Yang, E., Kim, N., Son, J. H., Kong, T. W., Shim, S. H., Suh, D. H., Chang, S. J., & Kim, H. S. (2026). Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002). Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e89

Vancouver

Han KH, Yang E, Kim N, Son JH, Kong TW, Shim SH, et al. Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002). Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e89

BibTeX
@article{Han2026,
  author = {Han, Kyung Hee and Yang, Eunjung and Kim, Namkyeong and Son, Joo-Hyuk and Kong, Tae Wook and Shim, Seung-Hyuk and Suh, Dong Hoon and Chang, Suk-Joon and Kim, Hee Seung},
  title = {Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002)},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  doi = {10.3802/jgo.2026.37.e89}
}
Kostenlos starten →